SINOVAC BIOTECH LTD (SVA) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $4.32M2010: $24.82M2011: $15.46M2012: $16.16M2013: $5.13M2014: $10.91M2015: $5.30M2016: $12.65M2017: $11.91M2018: $5.61M2019: $10.63M2020: $127.49M2021: $594.21M2022: $313.86M2023: $156.16M2024: $95.96M2025: $48.92M$48.92M
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$48.92M-49.0%
2024$95.96M-38.6%
2023$156.16M-50.2%
2022$313.86M-47.2%
2021$594.21M+366.1%
2020$127.49M+1099.5%
2019$10.63M+89.3%
2018$5.61M-52.9%
2017$11.91M-5.8%
2016$12.65M+138.8%
2015$5.30M-51.4%
2014$10.91M+112.6%
2013$5.13M-68.2%
2012$16.16M+4.5%
2011$15.46M-37.7%
2010$24.82M+474.5%
2009$4.32M